公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2015 | Menthols as Chiral Auxiliaries for Asymmetric Cycloadditive Oligomerization: Syntheses and Studies of β-Proline Hexamers | Kudryavtsev K.V.; Ivantcova P.M.; Muhle-Goll C.; Churakov A.V.; Sokolov M.N.; Dyuba A.V.; Arutyunyan A.M.; Howard J.A.K.; Yu C.-C.; JIH-HWA GUH ; Zefirov N.S.; Br?se S. | Organic Letters | 14 | 15 | |
2014 | MiR-200c and GATA binding protein 4 regulate human embryonic stem cell renewal and differentiation | Huang H.-N.; Chen S.-Y.; Hwang S.-M.; Yu C.-C.; Su M.-W.; Mai W.; Wang H.-W.; Cheng W.-C.; Schuyler S.C.; Ma N.; FRANK LEIGH LU ; Lu J. | Stem Cell Research | 43 | 37 | |
2002 | Modification of protein release from microparticles coated by chitosan | WEN-JEN LIN ; Yu C.-C. | Chinese Pharmaceutical Journal | 0 | ||
2013 | Molecular markers in key steroidogenic pathways, circulating steroid levels, and prostate cancer progression | L?vesque E.; Huang S.-P.; Audet-Walsh E.; Lacombe L.; Bao B.-Y.; Fradet Y.; Laverdi?re I.; Rouleau M.; CHAO-YUAN HUANG ; Yu C.-C.; Caron P.; Guillemette C. | Clinical Cancer Research | 49 | 44 | |
2013 | Molecular Markers in Sex Hormone Pathway Genes Associated with the Efficacy of Androgen-Deprivation Therapy for Prostate Cancer | Yu C.-C.; Huang S.-P.; Lee Y.-C.; CHAO-YUAN HUANG ; Liu C.-C.; Hour T.-C.; Huang C.-N.; You B.-J.; Chang T.-Y.; Huang C.-H.; Bao B.-Y. | PLoS ONE | 22 | 151 | |
2011 | A new framework and a simpler method for the development of batch crystallization recipes | Ward J.D. ; Yu C.-C.; Doherty M.F. | AIChE Journal | 20 | 18 | |
2011 | A new shortcut design method and economic analysis of divided wall columns | Chu K.-T.; Cadoret L.; Yu C.-C.; Ward J.D. | Industrial and Engineering Chemistry Research | 42 | 37 | |
2016 | Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: The role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways | Leu W.-J.; Swain S.P.; Chan S.-H.; Hsu J.-L.; SHIH-PING LIU ; Chan M.-L.; Yu C.-C.; LIH-CHING HSU ; Chou Y.-L.; Chang W.-L.; Hou D.-R.; JIH-HWA GUH | Oncotarget | 14 | 14 | |
2014 | Nondestructive characterization of the structural quality and thickness of large-area graphene on various substrates | Liu Y.-L.; Yu C.-C.; Lin K.-T.; Wang E.-Y.; Yang T.-C.; Chen H.-L.; Chen C.-W.; Chang C.-K.; Chen L.-C.; CHUN-WEI CHEN ; HSUEN-LI CHEN ; Chen, L.-C. | Analytical Chemistry | 8 | 8 | |
2013 | A novel hydroxysuberamide derivative potentiates MG132-mediated anticancer activity against human hormone refractory prostate cancers - The role of histone deacetylase and endoplasmic reticulum stress | Chen Y.-C.; Huang W.-J.; Hsu J.-L.; Yu C.-C.; Wang W.-T.; JIH-HWA GUH | Prostate | 6 | 6 | |
2020 | Novel robot-assisted laparoscopic total extra-peritoneal repair with primary fascial closure plus pre-peritonea mesh for large groin defects | Yu C.-C.; Lo C.-W.; Chen Y.-T.; Lin C.-D.; SHIH-CHIEH CHUEH ; Tsai Y.C. | International Journal of Medical Robotics and Computer Assisted Surgery | 4 | 4 | |
2014 | A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase i | Yu C.-C.; Pan S.-L.; Chao S.-W.; SHIH-PING LIU ; Hsu J.-L.; Yang Y.-C.; TSAI-KUN LI ; Huang W.-J.; JIH-HWA GUH | Biochemical Pharmacology | 29 | 28 | |
2021 | NRG1 genetic variant influences the efficacy of androgen-deprivation therapy in men with prostate cancer | Huang S.-P.; Chen Y.-T.; Chen L.-C.; Lee C.-H.; CHAO-YUAN HUANG ; Yu C.-C.; Lin V.C.; Lu T.-L.; Bao B.-Y. | Biomedicines | 2 | 3 | |
2005 | An oral delivery system for recombinant subunit vaccine to fish | HAN YOU LIN ; Yu C.-C.; Lin C.-C.; Yang H.-L. | Developments in Biologicals | |||
2013 | Osteopontin promoter polymorphisms are associated with susceptibility to gastric cancer | Lee T.-Y.; Lin J.-T.; Wu C.-C.; Yu C.-C.; MING-SHIANG WU ; Lee T.-C.; Chen H.-P.; Wu C.-Y. | Journal of Clinical Gastroenterology | 18 | 16 | |
2011 | Paclitaxel induces apoptosis through activation of nuclear protein kinase C-δ and subsequent activation of Golgi associated Cdk1 in human hormone refractory prostate cancer | Lu P.-H.; Yu C.-C.; Chiang P.-C.; Chen Y.-C.; Ho Y.-F.; FAN-LU KUNG ; JIH-HWA GUH | Journal of Urology | 16 | 14 | |
2019 | Phosphodiesterase type 5 (PDE5) inhibitors sensitize topoisomerase II inhibitors in killing prostate cancer through PDE5-independent impairment of HR and NHEJ DNA repair systems | Chang J.-F.; Hsu J.-L.; Sheng Y.-H.; Leu W.-J.; Yu C.-C.; Chan S.-H.; Chan M.-L.; LIH-CHING HSU ; SHIH-PING LIU ; JIH-HWA GUH | Frontiers in Oncology | 11 | 13 | |
2010 | Plantwide dynamics and control of processes with crystallization | Ward J.D. ; Yu C.-C.; Doherty M.F. | Computers and Chemical Engineering | 15 | 12 | |
2008 | Polymeric membrane studied using slow positron beam | Hung W.-S.; Lo C.-H.; Cheng M.-L.; Chen H.; Liu G.; Chakka L.; Nanda D.; Tung K.-L. ; Huang S.-H.; Lee K.-R.; Lai J.-Y.; Sun Y.-M.; Yu C.-C.; Zhang R.; Jean Y.C. | Applied Surface Science | 14 | 14 | |
2016 | Prognostic relevance of methylenetetrahydrofolate reductase polymorphisms for prostate cancer | Lin V.C.; Lu T.-L.; Yin H.-L.; Yang S.-F.; Lee Y.-C.; Liu C.-C.; CHAO-YUAN HUANG ; Yu C.-C.; Chang T.-Y.; Huang S.-P.; Bao B.-Y. | International Journal of Molecular Sciences | 7 | 4 |